Institution · Histogenics (United States)

Most cited papers from Histogenics (United States)

Histogenics (United States)

What are the most cited papers from Histogenics (United States)?

The most cited paper from Histogenics (United States) is "Correlating rheological properties and printability of collagen bioinks: the effects of riboflavin photocrosslinking and pH" (Nicole Diamantides, Louis Wang, Tylar Pruiksma et al., 2017), with 266 citations. Next come "Increased Tumor Penetration of Single-Domain Antibody–Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models" (130) and "High density cell seeding affects the rheology and printability of collagen bioinks" (126).

Published FieldAccessCitations

Showing 23 of 23 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Correlating rheological properties and printability of collagen bioinks: the effects of riboflavin photocrosslinking and pH Nicole Diamantides, Louis Wang, Tylar Pruiksma et al. · Biofabrication Open access	5 Jul 2017	266
2	Increased Tumor Penetration of Single-Domain Antibody–Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models Ian Nessler, Eshita Khera, Steven Vance et al. · Cancer Research Open access	15 Jan 2020	130
3	High density cell seeding affects the rheology and printability of collagen bioinks Nicole Diamantides, Caroline Dugopolski, Eric Blahut et al. · Biofabrication Open access	25 Jul 2019	126
4	Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody–Drug Conjugate Mirvetuximab Soravtansine Ursula A. Matulonis, Michael J. Birrer, David M. O’Malley et al. · Clinical Cancer Research	9 Nov 2018	87
5	IMGN779, a Novel CD33-Targeting Antibody–Drug Conjugate with DNA-Alkylating Activity, Exhibits Potent Antitumor Activity in Models of AML Yelena Kovtun, Paul Noordhuis, Kathleen R. Whiteman et al. · Molecular Cancer Therapeutics Open access	27 Mar 2018	80
6	Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors Tinya J. Abrams et al. · Clinical Cancer Research	15 May 2018	66
7	Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers Carl Uli Bialucha et al. · Cancer Discovery	19 May 2017	58
8	Mechanical properties and structure‐function relationships of human chondrocyte‐seeded cartilage constructs after in vitro culture Jill M. Middendorf, Darvin J. Griffin, Sonya Shortkroff et al. · Journal of Orthopaedic Research® Open access	7 Feb 2017	40
9	Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy Jose F. Ponte, Leanne Lanieri, Eshita Khera et al. · Molecular Cancer Therapeutics Open access	11 Nov 2020	39
10	Matrix-Induced Autologous Chondrocyte Implantation (MACI) Using a Cell-Seeded Collagen Membrane Improves Cartilage Healing in the Equine Model Alan J. Nixon, Holly D. Sparks, Laila Begum et al. · Journal of Bone and Joint Surgery	6 Dec 2017	36
11	An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities Céline Nicolazzi, Anne Caron, Alexia Tellier et al. · Molecular Cancer Therapeutics	25 May 2020	32
12	Nerve Injury Complicating Multiligament Knee Injury: Current Concepts and Treatment Algorithm William R. Mook, Cassandra A. Ligh, Claude T. Moorman et al. · Journal of the American Academy of Orthopaedic Surgeons	Jun 2013	31
13	ErbB3–ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas Claudia Capparelli, Sheera R. Rosenbaum, Lisa D. Berman-Booty et al. · Cancer Research Open access	23 Jul 2015	24
14	In vitro culture increases mechanical stability of human tissue engineered cartilage constructs by prevention of microscale scaffold buckling Jill M. Middendorf, Sonya Shortkroff, Caroline Dugopolski et al. · Journal of Biomechanics	14 Sep 2017	19
15	Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody–Drug Conjugate in Patient-derived Xenografts Adnan O. Abu‐Yousif et al. · Molecular Cancer Therapeutics	11 Aug 2020	17
16	Heterogeneous matrix deposition in human tissue engineered cartilage changes the local shear modulus and resistance to local construct buckling Jill M. Middendorf, Caroline Dugopolski, Stephen M. Kennedy et al. · Journal of Biomechanics Open access	24 Mar 2020	16
17	Multiscale mechanics of tissue‐engineered cartilage grown from human chondrocytes and human‐induced pluripotent stem cells Jill M. Middendorf, Nicole Diamantides, Sonya Shortkroff et al. · Journal of Orthopaedic Research® Open access	3 Mar 2020	14
18	Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia Sankaranarayanan Kannan, Marisa J.L. Aitken, Shelley M. Herbrich et al. · Molecular Cancer Therapeutics Open access	21 Jun 2019	14
19	The Role of Buckling Instabilities in the Global and Local Mechanical Response in Porous Collagen Scaffolds Byumsu Kim, Jill M. Middendorf, Nicole Diamantides et al. · Experimental Mechanics	3 Jun 2022	10
20	The influence of chondrocyte source on the manufacturing reproducibility of human tissue engineered cartilage Jill M. Middendorf, Nicole Diamantides, Byumsu Kim et al. · Acta Biomaterialia Open access	8 Jul 2021	4
21	Long-Term Failure Rates Associated With Knee Microfracture Surgery AJ Layton, Renée J.G. Arnold, J. Graham et al. · Value in Health Open access	May 2015	4
22	Repairing Cartilage with Processed Chondrocyte Constructs: A 6-Month Study Using a Porcine Model Akihiko Kusanagi, Eric Blahut, Takahiro Ogura et al. · Cartilage Open access	11 Nov 2021	2
23	In vitro migration of mesenchymal stem cells (MSC) promotes differentiation to chondrocytes Joseph David Khoury, Laura R. Geuss, Sonya Shortkroff et al. · The FASEB Journal	Mar 2008	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.